• JAMA · Jun 2012

    IOM urges FDA to be more aggressive in monitoring safety of approved drugs.

    • Bridget M Kuehn.
    • JAMA. 2012 Jun 20; 307 (23): 2475-6.

    no abstract available

      Pubmed     Full text   Copy Citation  

      Add institutional full text...

    Notes

    hide…